Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Meningioma × Octreotide × Clear all

Sponsor

Conditions

Neuroendocrine Tumors 6 Neoplasms 4 Carcinoid Tumor 4 Carcinoma 3 Vipoma 2 Neoplasm Metastasis 2 Intestinal Obstruction 2 Carcinoma, Islet Cell 2 Somatostatinoma 1 Recurrence 1 Prostatic Neoplasms 1 Primary Inoperable Thymoma 1 Pleural Effusion 1 Peritoneal Neoplasms 1 Malignant Carcinoid Syndrome 1 Lymphangiomyoma 1 Lymphangioleiomyomatosis 1 Insulinoma 1 Glucagonoma 1 Gastro-enteropancreatic neuroendocrine tumor 1 Gastrinoma 1 Diarrhea 1 Chylous Ascites 1 Chylothorax 1 Carcinoma, Neuroendocrine 1 Breast Neoplasms 1 Ascites 1 Adenoma, Islet Cell 1

Interventions

Hydroxyurea 3 Bevacizumab 3 pembrolizumab 2 Imatinib Mesylate 2 Everolimus 2 vatalanib 1 pasireotide 1 fludarabine phosphate 1 fludarabine 1 arginyllysine 1 antineoplaston AS 2-1 1 antineoplaston A10 1 aldesleukin 1 Whole Body Imaging 1 Verapamil 1 Sunitinib 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Image-Guided 1 Radiotherapy, Conformal 1 Radiotherapy 1 Radiosurgery 1 Proton Therapy 1 Nivolumab 1 Modafinil 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 Fentanyl 1 Erlotinib Hydrochloride 1 Donepezil 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡